Déjà vu
One theory of déjà vu attributes the feeling of having previously seen or experienced something to having dreamed about a similar situation or place, and forgetting about it until one seems to be mysteriously reminded of the situation or the place while awake. See also
References
Further reading
Dreaming (journal)
Jung, Carl (1934). The Practice of Psychotherapy. "The Practical Use of Dream-analysis". New York: Routledge & Kegan Paul. pp. 139–. ISBN 978-0-7100-1645-4. Jung, Carl (2002). Dreams (Routledge Classics). New York: Routledge. ISBN 978-0-415-26740-3. Harris, William V. (2009) Dreams and Еxperience in Classical Antiquity. Cambridge, MA & London: Harvard University Press. External links

Dreams on In Our Time at the BBC
LSDBase – an online sleep research database documenting the physiological effects of dreams through biofeedback. Archive for Research in Archetypal Symbolism website
The International Association for the Study of Dreams
Dream at Curlie
Dixit, Jay (November 2007). "Dreams: Night School". Psychology Today. Retrieved December 1, 2018.
alt.dreams A long-running USENET forum wherein readers post and analyze dreams.
Amphotericin B molecules can form pores in the host membrane as well as the fungal membrane. This impairment in membrane barrier function can have lethal effects. Ergosterol, the fungal sterol, is more sensitive to amphotericin B than cholesterol, the common mammalian sterol. Reactivity with the membrane is also sterol concentration dependent. Bacteria are not affected as their cell membranes do not usually contain sterols. Amphotericin administration is limited by infusion-related toxicity. This is thought to result from innate immune production of proinflammatory cytokines. Biosynthesis
The natural route to synthesis includes polyketide synthase components. The carbon chains of Amphotericin B are assembled from sixteen C2 acetate and three C3propionate units by polyketide syntheses (PKSs). Polyketide biosynthesis begins with the decarboxylative condensation of a dicarboxylic acid extender unit with a starter acyl unit to form a β-ketoacyl intermediate. The growing chain is constructed by a series of Claisen reactions. Within each module, the extender units are loaded onto the current ACP domain by acetyl transferase (AT). The ACP-bound elongation group reacts in a Claisen condensation with the KS-bound polyketide chain. Ketoreductase (KR), dehydratase (DH) and enoyl reductase (ER) enzymes may also be present to form alcohol, double bonds or single bonds. After cyclisation, the macrolactone core undergoes further modification by hydroxylation, methylation and glycosylation. The order of these processes is unknown. History
It was originally extracted from Streptomyces nodosus, a filamentous bacterium, in 1955, at the Squibb Institute for Medical Research from cultures of an undescribed streptomycete isolated from the soil collected in the Orinoco River region of Venezuela.